SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029273
Filing Date
2022-08-12
Accepted
2022-08-12 15:01:09
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 ISCO-Q2-06302022 isco-10q_20220630.htm   iXBRL 10-Q 2198513
2 EX-31.1 isco-ex311_8.htm EX-31.1 9367
3 EX-31.2 isco-ex312_9.htm EX-31.2 9287
4 EX-32.1 isco-ex321_7.htm EX-32.1 6048
5 EX-32.2 isco-ex322_6.htm EX-32.2 6545
  Complete submission text file 0001564590-22-029273.txt   9631429

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA isco-20220630.xsd EX-101.SCH 58264
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20220630_cal.xml EX-101.CAL 46147
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20220630_def.xml EX-101.DEF 176191
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20220630_lab.xml EX-101.LAB 390205
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20220630_pre.xml EX-101.PRE 306031
63 EXTRACTED XBRL INSTANCE DOCUMENT isco-10q_20220630_htm.xml XML 2384513
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 221159565
SIC: 2834 Pharmaceutical Preparations